123 related articles for article (PubMed ID: 12411755)
1. Abnormal vitamin D metabolism and loss of bone mass after renal transplantation.
de Sévaux RG; Hoitsma AJ; van Hoof HJ; Corstens FJ; Wetzels JF
Nephron Clin Pract; 2003 Jan; 93(1):C21-8. PubMed ID: 12411755
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation.
Westeel FP; Mazouz H; Ezaitouni F; Hottelart C; Ivan C; Fardellone P; Brazier M; El Esper I; Petit J; Achard JM; Pruna A; Fournier A
Kidney Int; 2000 Oct; 58(4):1788-96. PubMed ID: 11012914
[TBL] [Abstract][Full Text] [Related]
3. Treatment with vitamin D and calcium reduces bone loss after renal transplantation: a randomized study.
De Sévaux RG; Hoitsma AJ; Corstens FH; Wetzels JF
J Am Soc Nephrol; 2002 Jun; 13(6):1608-14. PubMed ID: 12039990
[TBL] [Abstract][Full Text] [Related]
4. Changes in bone mineral density over 18 months following kidney transplantation: the respective roles of prednisone and parathyroid hormone.
Casez JP; Lippuner K; Horber FF; Montandon A; Jaeger P
Nephrol Dial Transplant; 2002 Jul; 17(7):1318-26. PubMed ID: 12105258
[TBL] [Abstract][Full Text] [Related]
5. Changes in bone mineral density and selected metabolic parameters over 24 months following renal transplantation.
Al-Gabri S; Zadrazil J; Krejcí K; Horák P; Bachleda P
Transplant Proc; 2005 Mar; 37(2):1014-9. PubMed ID: 15848609
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of bone mineral density after renal transplantation under a tacrolimus-based immunosuppression: a pilot study.
Goffin E; Devogelaer JP; Depresseux G; Squifflet JP; Pirson Y; van Yperselede de Strihou C
Clin Nephrol; 2003 Mar; 59(3):190-5. PubMed ID: 12653262
[TBL] [Abstract][Full Text] [Related]
7. Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study.
Shane E; Rodino MA; McMahon DJ; Addesso V; Staron RB; Seibel MJ; Mancini D; Michler RE; Lo SH
J Heart Lung Transplant; 1998 Nov; 17(11):1089-96. PubMed ID: 9855448
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D, parathyroid hormone, and bone mineral density status in kidney transplant recipients.
Savaj S; Ghods FJ
Iran J Kidney Dis; 2012 Jul; 6(4):295-9. PubMed ID: 22797100
[TBL] [Abstract][Full Text] [Related]
9. Sequential changes of biochemical bone parameters after kidney transplantation.
Reinhardt W; Bartelworth H; Jockenhövel F; Schmidt-Gayk H; Witzke O; Wagner K; Heemann UW; Reinwein D; Philipp T; Mann K
Nephrol Dial Transplant; 1998 Feb; 13(2):436-42. PubMed ID: 9509459
[TBL] [Abstract][Full Text] [Related]
10. Lumbar bone mineral density in renal transplant patients on neoral and tacrolimus: a four-year prospective study.
Marcén R; Caballero C; Pascual J; Teruel JL; Tenorio M; Ocaña J; Villafruela JJ; Burgos FJ; Fernández AM; Muriel A; Ortuño J
Transplantation; 2006 Mar; 81(6):826-31. PubMed ID: 16570003
[TBL] [Abstract][Full Text] [Related]
11. Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A.
Monegal A; Navasa M; Guañabens N; Peris P; Pons F; Martínez de Osaba MJ; Rimola A; Rodés J; Muñoz-Gómez J
Calcif Tissue Int; 2001 Feb; 68(2):83-6. PubMed ID: 11310351
[TBL] [Abstract][Full Text] [Related]
12. Development of lumbar bone mineral density in the late course after kidney transplantation.
Brandenburg VM; Ketteler M; Fassbender WJ; Heussen N; Freuding T; Floege J; Ittel TH
Am J Kidney Dis; 2002 Nov; 40(5):1066-74. PubMed ID: 12407653
[TBL] [Abstract][Full Text] [Related]
13. Influence of tacrolimus and short-duration prednisone on bone mineral density following liver transplantation.
Scolapio JS; DeArment J; Hurley DL; Romano M; Harnois D; Weigand SD
JPEN J Parenter Enteral Nutr; 2003; 27(6):427-32. PubMed ID: 14621125
[TBL] [Abstract][Full Text] [Related]
14. Effect of pamidronate on bone loss after kidney transplantation: a randomized trial.
Walsh SB; Altmann P; Pattison J; Wilkie M; Yaqoob MM; Dudley C; Cockwell P; Sweny P; Banks LM; Hall-Craggs M; Noonan K; Andrews C; Cunningham J
Am J Kidney Dis; 2009 May; 53(5):856-65. PubMed ID: 19393473
[TBL] [Abstract][Full Text] [Related]
15. Influence of vitamin D receptor gene polymorphisms on secondary hyperparathyroidism and bone density after kidney transplantation.
Falkiewicz K; Bidzińska B; Demissie M; Boratyńska M; Zmonarski SC; Tworowska K; Klinger M; Milewicz A; Patrzałek D
Transplant Proc; 2005 Mar; 37(2):1023-5. PubMed ID: 15848611
[TBL] [Abstract][Full Text] [Related]
16. Prevention of cancellous bone loss but persistence of renal bone disease despite normal 1,25 vitamin D levels two years after kidney transplantation.
Briner VA; Thiel G; Monier-Faugere MC; Bognar B; Landmann J; Kamber V; Malluche HH
Transplantation; 1995 May; 59(10):1393-400. PubMed ID: 7770924
[TBL] [Abstract][Full Text] [Related]
17. Evolution of bone disease at 2 years after transplantation: a single-center study.
Falkiewicz K; Boratyńska M; Zmonarski SC; Milewicz A; Patrzałek D; Biecek P; Klinger M
Transplant Proc; 2009 Oct; 41(8):3063-6. PubMed ID: 19857677
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation.
Thiébaud D; Krieg MA; Gillard-Berguer D; Jacquet AF; Goy JJ; Burckhardt P
Eur J Clin Invest; 1996 Jul; 26(7):549-55. PubMed ID: 8864416
[TBL] [Abstract][Full Text] [Related]
19. Reduced bone mineral density in male renal transplant recipients: evidence for persisting hyperparathyroidism.
Roe SD; Porter CJ; Godber IM; Hosking DJ; Cassidy MJ
Osteoporos Int; 2005 Feb; 16(2):142-8. PubMed ID: 15258722
[TBL] [Abstract][Full Text] [Related]
20. The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis.
Deane A; Constancio L; Fogelman I; Hampson G
BMC Musculoskelet Disord; 2007 Jan; 8():3. PubMed ID: 17214897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
